Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4853049
Max Phase: Preclinical
Molecular Formula: C26H36N3O3P
Molecular Weight: 469.57
Molecule Type: Unknown
Associated Items:
ID: ALA4853049
Max Phase: Preclinical
Molecular Formula: C26H36N3O3P
Molecular Weight: 469.57
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](CP(=O)(O)[C@@H](N)CCc1ccccc1)C(=O)NCCc1c[nH]c2ccccc12
Standard InChI: InChI=1S/C26H36N3O3P/c1-19(2)16-22(18-33(31,32)25(27)13-12-20-8-4-3-5-9-20)26(30)28-15-14-21-17-29-24-11-7-6-10-23(21)24/h3-11,17,19,22,25,29H,12-16,18,27H2,1-2H3,(H,28,30)(H,31,32)/t22-,25-/m1/s1
Standard InChI Key: GZADYKQLFNISTG-RCZVLFRGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 469.57 | Molecular Weight (Monoisotopic): 469.2494 | AlogP: 4.68 | #Rotatable Bonds: 12 |
Polar Surface Area: 108.21 | Molecular Species: ZWITTERION | HBA: 3 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 0.02 | CX Basic pKa: 9.61 | CX LogP: 2.89 | CX LogD: 2.89 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.29 | Np Likeness Score: -0.05 |
1. Wilding B, Pasqua AE, E A Chessum N, Pierrat OA, Hahner T, Tomlin K, Shehu E, Burke R, Richards GM, Whitton B, Arwert EN, Thapaliya A, Salimraj R, van Montfort R, Skawinska A, Hayes A, Raynaud F, Chopra R, Jones K, Newton G, Cheeseman MD.. (2021) Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1., 42 [PMID:33887439] [10.1016/j.bmcl.2021.128050] |
Source(1):